{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Olaparib Maintenance Therapy in BRCA-Mutated Pancreatic Ductal Adenocarcinoma"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This single-arm trial was conducted at a tertiary care center."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were adults with BRCA2-mutated UR-M PDAC."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention involved 8 courses of mFFX followed by 8 months of olaparib."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy of olaparib maintenance therapy following modified FOLFIRINOX (mFFX) in achieving surgical resectability."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the rate of conversion to resectable disease, assessed by imaging and surgical exploration."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and blinding were not applicable due to the single-arm design."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Randomisation and blinding were not applicable due to the single-arm design."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "One participant was enrolled and completed the intervention."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "The analysis was per-protocol."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The primary tumor showed over 60% shrinkage, and hepatic metastases disappeared."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events included neuropathy due to mFFX, managed by switching to olaparib."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not disclosed."
      }
    },
    "total_score": 14,
    "max_score": 25
  },
  "model": "gpt-4o"
}